These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial. Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931 [TBL] [Abstract][Full Text] [Related]
10. Cytisine as a smoking cessation aid: Preliminary observations with a modified therapeutic scheme in real life. Pozzi P; Boffi R; Veronese C; Trussardo S; Valsecchi C; Sabia F; Pastorino U; Apolone G; Cardani E; Tarantini F; Munarini E Tumori; 2024 Apr; 110(2):124-131. PubMed ID: 38149659 [TBL] [Abstract][Full Text] [Related]
11. Public Health Impact of FDA's Request for Additional Safety Data on Cytisine for Tobacco Cessation. Reddy KP; Paltiel AD; Freedberg KA; Rigotti NA JAMA Health Forum; 2024 Aug; 5(8):e242647. PubMed ID: 39177985 [TBL] [Abstract][Full Text] [Related]
12. Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation. Tutka P; Vinnikov D; Courtney RJ; Benowitz NL Addiction; 2019 Nov; 114(11):1951-1969. PubMed ID: 31240783 [TBL] [Abstract][Full Text] [Related]
13. The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial. Thomas D; Farrell M; McRobbie H; Tutka P; Petrie D; West R; Siahpush M; Gartner C; Walker N; Mendelsohn CP; Hall W; Paul C; Zwar N; Ferguson SG; Boland VC; Richmond R; Doran CM; Shakeshaft A; Mattick RP; Courtney RJ Addiction; 2019 May; 114(5):923-933. PubMed ID: 30589984 [TBL] [Abstract][Full Text] [Related]
14. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation. Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822 [TBL] [Abstract][Full Text] [Related]
15. An uncontrolled trial of cytisine (Tabex) for smoking cessation. Zatonski W; Cedzynska M; Tutka P; West R Tob Control; 2006 Dec; 15(6):481-4. PubMed ID: 17130378 [TBL] [Abstract][Full Text] [Related]
16. Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking. Walker N; Howe C; Bullen C; McRobbie H; Glover M; Parag V; Williman J; Veale R; Nosa V; Barnes J BMC Public Health; 2011 Nov; 11():880. PubMed ID: 22104038 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effectiveness of cytisine for the treatment of smoking cessation: A systematic review and meta-analysis. De Santi O; Orellana M; Di Niro CA; Greco V Addiction; 2024 Apr; 119(4):649-663. PubMed ID: 38161271 [TBL] [Abstract][Full Text] [Related]
18. Cytisine for smoking cessation: a research agenda. Etter JF; Lukas RJ; Benowitz NL; West R; Dresler CM Drug Alcohol Depend; 2008 Jan; 92(1-3):3-8. PubMed ID: 17825502 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cahill K; Stevens S; Perera R; Lancaster T Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690 [TBL] [Abstract][Full Text] [Related]